Park City Angels

Type

Angel Group/Syndicate

Status

Active

Location

Paris, France

Total investments

12

Average round size

1M

Portfolio companies

10

Rounds per year

0.80

Follow on index

0.17

Exits

1

Stages of investment
Seed
Areas of investment
BiotechnologySoftwareFinanceHealth CareMedical DeviceRenewable EnergyNatural ResourcesEnergy EfficiencySmart CitiesClinical Trials

Summary

Park City Angels appeared to be the VC, which was created in 2007. The leading representative office of defined VC is situated in the Park City. The fund was located in North America if to be more exact in United States.

The current fund was established by Ted McAleer.

The high activity for fund was in 2015. The fund is generally included in less than 2 deals every year. The real fund results show that this VC is 6 percentage points less often commits exit comparing to other companies. Opposing the other organizations, this Park City Angels works on 15 percentage points less the average amount of lead investments. The typical startup value when the investment from Park City Angels is 5-10 millions dollars. The common things for fund are deals in the range of 100 thousands - 1 million dollars. The higher amount of exits for fund were in 2016.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Park City Angels, startups are often financed by Kickstart Seed Fund, BoomStartup, Utah Angels 2. The meaningful sponsors for the fund in investment in the same round are Kickstart Seed Fund, Wilmington Pharmatech, Utah Angels 2. In the next rounds fund is usually obtained by Intermountain Healthcare, Healthbox, Eurovestech.

We can highlight the next thriving fund investment areas, such as Genetics, Service Industry. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Tute Genomics

Show more

Investor highlights

Stage focus
Seed

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
12
Lead investments
0
Exits
1
Rounds per year
0.80
Follow on index
0.17
Investments by industry
  • Biotechnology (4)
  • Software (4)
  • Health Care (3)
  • Smart Cities (2)
  • Finance (2)
  • Show 33 more
Investments by region
  • United States (11)
Peak activity year
2015

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
7
Avg. valuation at time of investment
900K
Group Appearance index
0.83
Avg. company exit year
4

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Every 28 Dec 2017 Video, Digital Media, Recipes Late Stage Venture 19M Chiba Prefecture, Tateyama, Japan
Veristride, Inc. 01 Jul 2015 Analytics, Consumer Electronics, Service Industry Seed 815K Salt Lake City, Utah, United States
Nivati 11 Sep 2018 Software, Human Resources, Health Care, Wellness, Personal Health, Employee Benefits Seed 635K Utah, United States, South Jordan

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.